Evidence map›Paper›PMID 10669416›Full record

ArticleScience (New York, N.Y.)2000

Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

T Sasaki, J Irie-Sasaki, R G Jones, A J Oliveira-dos-Santos, W L Stanford, B Bolon, A Wakeham, A Itie, D Bouchard, I Kozieradzki and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 369 papers.

0numbers the graph read from it
0cells of the map it votes in
369citing papers in PubMed
32.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

369 citing papers in PubMed, 1,024 citations in OpenAlex.

  1. Trial
  2. Trial
  3. A renaissance in targeting the PI3K/AKT/mTOR pathway.Nature reviews. Drug discovery · 2026
    Review
  4. Article
  5. Article
  6. Targeting PI3Kγ in cancer.Trends in cancer · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

309 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

T SasakiAmgen Institute, 620 University Avenue, Toronto M5G 2C1, Ontario, Canada.
J Irie-Sasaki
R G Jones
A J Oliveira-dos-Santos
W L Stanford
B Bolon
A Wakeham
A Itie
D Bouchard
I Kozieradzki
N Joza
T W Mak
P S Ohashi
A Suzuki
J M Penninger
Ontario Institute for Cancer Research · CACancer Institute (WIA) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphoinositide 3-kinases (PI3Ks) regulate fundamental cellular responses such as proliferation, apoptosis, cell motility, and adhesion. Viable gene-targeted mice lacking the p110 catalytic subunit of PI3Kgamma were generated. We show that PI3Kgamma controls thymocyte survival and activation of mature T cells but has no role in the development or function of B cells. PI3Kgamma-deficient neutrophils exhibited severe defects in migration and respiratory burst in response to heterotrimeric GTP-binding protein (G protein)-coupled receptor (GPCR) agonists and chemotactic agents. PI3Kgamma links GPCR stimulation to the formation of phosphatidylinositol 3,4,5-triphosphate and the activation of protein kinase B, ribosomal protein S6 kinase, and extracellular signal-regulated kinases 1 and 2. Thus, PI3Kgamma regulates thymocyte development, T cell activation, neutrophil migration, and the oxidative burst.

Indexed as

Lymphocyte ActivationProtein Serine-Threonine KinasesAnimalsAntigens, CDApoptosisCell LineChemotactic FactorsChemotaxis, LeukocyteHeterotrimeric GTP-Binding ProteinsLymph NodesMiceMice, KnockoutMitogen-Activated Protein KinasesNeutrophilsPeritonitisPhosphatidylinositol 3-KinasesAntigens, CDChemotactic FactorsHeterotrimeric GTP-Binding ProteinsMitogen-Activated Protein Kinasesphosphatidylinositol 3,4,5-triphosphatePhosphatidylinositol 3-KinasesPhosphatidylinositol PhosphatesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-akt

Identifiers

PMID10669416
OpenAlexW2163579392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.